PNC Financial Services Group’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
Other funds holding SANA
FP
RCM
MG
PNC Financial Services Group's SANA Position: Q2 2026 in Review
PNC Financial Services Group increased its Sana Biotechnology (SANA) stake by 8.4% in Q2 2026, buying an estimated $3.25K and bringing the position to 13,052 shares worth $45.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3399.
PNC Financial Services Group first reported a position in SANA in Q1 2021 and has held it in 20 quarters since. The position peaked at $49K in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.
- PNC Financial Services Group held 13,052 shares of Sana Biotechnology worth $45.6K as of Q2 2026.
- PNC Financial Services Group bought 1,009 Sana Biotechnology shares in Q2 2026, an estimated $3.25K.
- Sana Biotechnology made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3399 holding.
- PNC Financial Services Group first reported a position in Sana Biotechnology in Q1 2021 and has held it in 20 quarters since.
- PNC Financial Services Group's Sana Biotechnology position peaked at $49K in Q4 2025.
- 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.